|
|
|
Volumn 37, Issue 5, 2012, Pages
|
|
FDA considers a new paradigm: For over-the-counter medications: More power-but more burdens-for pharmacists and pharmacies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENALIN;
ANTIHYPERTENSIVE AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BISOPROLOL;
CARDICOR;
CORTICOSTEROID;
FEXOFENADINE;
GLYCOSYLATED HEMOGLOBIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
ISOTRETINOIN;
LORATADINE;
MEVINOLIN;
NON PRESCRIPTION DRUG;
UNCLASSIFIED DRUG;
ALLERGIC REACTION;
ASTHMA;
CERTIFICATION;
CLINICAL PRACTICE;
COMORBIDITY;
DIABETES CONTROL;
DIABETES MELLITUS;
DIABETIC PATIENT;
DIAGNOSTIC TEST;
DRUG CONTRAINDICATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG SAFETY;
EDITORIAL;
EDUCATION PROGRAM;
ELECTRONIC MEDICAL RECORD;
EMERGENCY WARD;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
GENERAL PRACTITIONER;
HEALTH CARE COST;
HEALTH CARE PERSONNEL;
HEALTH CARE SYSTEM;
HEALTH PLAN EMPLOYER DATA AND INFORMATION SET;
HEALTH PROGRAM;
HEART FAILURE;
HEMOGLOBIN BLOOD LEVEL;
HOSPITAL DISCHARGE;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNIZATION;
INFLUENZA;
INFLUENZA VACCINATION;
MEDICAL EDUCATION;
MEDICAL SCHOOL;
MEDICARE;
MEDICATION THERAPY MANAGEMENT;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
PHARMACIST;
PHARMACY;
PRESCRIPTION;
PRIVATE HEALTH INSURANCE;
PUBLIC HEALTH;
REIMBURSEMENT;
RISK FACTOR;
|
|
EID: 84863661681
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (1)
|
